Patrick Maisonneuve
Observed names: MAISONNEUVE P, MAISONNEUVE P., MAISSONEUVE P, MAISSONEUVE P., Maisonneuve P, Maisonneuve Patrick, Maisonneuve, P, Maisonneuve, P., Maisonneuve, Patrick, P MAISONNEUVE, P Maisonneuve, P Maissoneuve, P. MAISONNEUVE, P. Maisonneuve, P. Maissoneuve, P., Maisonneuve, PATRICK MAISONNEUVE, Patrick Maissoneuve, Patrik Maisonneuve
Observed institutions: University of Pisa, Universitat de Miguel Hernández d'Elx, Tulane University, University of Verona, Merck & Co., Inc., Rahway, NJ, USA (United States), Cliniques Universitaires Saint-Luc, Sunnybrook Health Science Centre, Memorial Sloan Kettering Cancer Center, Karolinska University Hospital, Harvard University, University of Liverpool, Inserm, University of California, Los Angeles, University of Pittsburgh, German Cancer Research Center, New York Medical College, University of Toronto, University of Milan, Mario Negri Institute for Pharmacological Research, QIMR Berghofer Medical Research Institute, University of Michigan, University Hospital of Bern, Institut Jules Bordet, Erasmus MC, Copenhagen University Hospital, Rigshospitalet, Karolinska Institutet, Ente Ospedaliero Ospedali Galliera, Italian Institute of Technology, Yale University, University of Belgrade, Ospedale Antonio Cardarelli, Luigi Sacco Hospital, Centro Cardiologico Monzino, Spanish National Cancer Research Centre, Istituto per lo Studio e la Prevenzione Oncologica, Bristol-Myers Squibb (United States), Hôpital Cochin, Azienda Ospedaliera Universitaria Integrata Verona, Azienda Ospedaliera San Camillo-Forlanini, UPMC Health System, Moriggia Pelascini Hospital, Azienda Ospedaliera di Cosenza, Fondazione Salvatore Maugeri, Centre Léon Bérard, University Hospital Olomouc, European School of Molecular Medicine, IFOM, Klinikum Lüneburg, Lega Italiana per la Lotta ai Tumori, University Hospital Leipzig, Instituto Ramón y Cajal de Investigación Sanitaria, Centro di Riferimento Oncologico, Hospital Universitario de La Princesa, University of Pittsburgh Medical Center, Ospedale Cannizzaro, Hospital General Universitario de Alicante Doctor Balmis, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Center for Genomic Science, Weill Cornell Medical College in Qatar, Pfizer (Canada), Fondazione IRCCS Istituto Nazionale dei Tumori, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Ramón y Cajal, Centre international de recherche sur le cancer, Weill Cornell Medicine, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), University of Bari Aldo Moro, European Institute of Oncology, University of Milano-Bicocca, University of Naples Federico II, University of Göttingen, University of Birmingham, University of Genoa, Sapienza University of Rome, University of Lausanne, KU Leuven
ORCID: 0000-0002-5309-4704
Observed ORCID: 0000-0002-5309-4704
OpenAlex ID: A5013117107